BeOne Medicines (BEIGF) Net Margin (2016 - 2025)
Historic Net Margin for BeOne Medicines (BEIGF) over the last 11 years, with Q3 2025 value amounting to 8.84%.
- BeOne Medicines' Net Margin rose 209600.0% to 8.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year increase of 273200.0%. This contributed to the annual value of 16.92% for FY2024, which is 189400.0% up from last year.
- As of Q3 2025, BeOne Medicines' Net Margin stood at 8.84%, which was up 209600.0% from 7.17% recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Net Margin registered a high of 27.57% during Q3 2023, and its lowest value of 320.24% during Q2 2021.
- For the 5-year period, BeOne Medicines' Net Margin averaged around 83.9%, with its median value being 57.94% (2023).
- Per our database at Business Quant, BeOne Medicines' Net Margin soared by 7405000bps in 2021 and then plummeted by -1529100bps in 2022.
- BeOne Medicines' Net Margin (Quarter) stood at 276.04% in 2021, then surged by 58bps to 117.16% in 2022, then soared by 51bps to 57.94% in 2023, then surged by 77bps to 13.47% in 2024, then skyrocketed by 166bps to 8.84% in 2025.
- Its Net Margin stands at 8.84% for Q3 2025, versus 7.17% for Q2 2025 and 0.11% for Q1 2025.